“Quality downstream applications are key to maximizing the full potential of in vivo study results, including our wealth of historical model and treatment data,”
ABSCI CLOSES $15.4 M IN SERIES D FUNDING TO ACCELERATE GROWTH AND SCALE DISRUPTIVE PROTEIN PRINTINGTM TECHNOLOGY, ANNOUNCES EXCLUSIVE CO-MARKETING PARTNERSHIP WITH KBI BIOPHARMA
JSR will develop technologies related to maintaining homeostasis of gut microbiota and in vitro diagnostic products through the JSR-Keio University Medical and Chemical Innovation Center (JKiC).
CrownBio has expanded its CVMD services capacity by investing in facilities at the University of Louisiana at Lafayette’s New Iberia Research Center (NIRC), the largest national primate research ce...